Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey.

Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey – The Lancet Oncology

Commentaries:

Access to and affordability of cancer medicines: time to focus on the last mile – The Lancet Oncology

Choosing Wisely, Researchers Look at Access to Essential Cancer Drugs on a Global Scale – The ASCO Post

Related: WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists.